Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

The hydrogel with neem and tridax extracts effectively treats seborrheic dermatitis.

Newly made nicotinamide compounds could potentially treat cancer.

Combining isotretinoin and dapsone effectively treated a challenging scalp condition.

Azelaic acid in a special gel is more effective against skin fungi than regular azelaic acid.

The AC 2 peptide from Trapa japonica fruit helps protect hair cells and may treat hair loss.

Baricitinib is a promising treatment for alopecia areata.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Baricitinib helps with early hair regrowth in people with alopecia areata.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Apocynin may protect skin cells from aging and damage caused by UVB light.

Diphenylcyclopropenone treatment helps hair growth in alopecia areata by promoting blood vessel growth and cell survival.

DPCP is effective for treating severe alopecia areata, but relapse is common.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

A girl with a rare skin condition improved after one month of treatment with acitretin.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Adapalene, Diosmin, and Azelastine could be repurposed to treat onchocerciasis.

Stopping isoniazid can reverse hair loss caused by the drug.

Intradermal testing can better detect corticosteroid allergies than patch testing.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tridax procumbens has medicinal properties.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Oral baricitinib is effective and safe for treating alopecia areata.